Camp4 Therapeutics

(NASDAQ) CAMP

Current Price$4.11

Market Cap$213.42M

Since IPO (2024)-62%

5 YearN/A

1 Year+121%

1 Month+1%

Camp4 Therapeutics Financials at a Glance

Market Cap

$213.42M

Revenue (TTM)

$3.93M

Net Income (TTM)

-$86.30M

EPS (TTM)

-$2.27

P/E Ratio

-1.81

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$4.11

Volume

68,957

Open

$4.24

Price

$4.11

Volume

68,957

Open

$4.24

Previous Close

$4.11

Daily Range

$4.00 - $4.46

52-Week Range

$1.31 - $7.75

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$4.11

Volume

68,957

Open

$4.24

Previous Close

$4.11

Daily Range

$4.00 - $4.46

52-Week Range

$1.31 - $7.75

Estimated Earnings Date

Aug 13, 2026

CAMP News

Camp4 Reports Q2 Revenue Beats Estimates

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Camp4 Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Josh Mandel-Brehm, MBA

Website

www.camp4tx.com

Headquarters

Cambridge, MA 02139, US

CAMP Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-13%

Net Income Margin

-22%

Return on Equity

-209%

Return on Capital

-59%

Return on Assets

-82%

Earnings Yield

-55.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$213.42M

Shares Outstanding

51.93M

Volume

68.96K

Avg. Volume

189.50K

Financials (TTM)

Gross Profit

$1.86M

Operating Income

-$52.06M

EBITDA

-$50.42M

Operating Cash Flow

-$29.55M

Capital Expenditure

-$279.00K

Free Cash Flow

-$29.83M

Cash & ST Invst.

$109.52M

Total Debt

$1.97M

Camp4 Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.29M

+50.8%

Gross Profit

$774.00K

-9.8%

Gross Margin

59.81%

N/A

Market Cap

$213.42M

N/A

Market Cap/Employee

$3.88M

N/A

Employees

N/A

Net Income

-$18.33M

-47.4%

EBITDA

-$12.55M

+1.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$97.09M

+134.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.74M

-63.5%

Short Term Debt

$384.00K

-87.7%

Return on Assets

-81.84%

N/A

Return on Invested Capital

-58.57%

N/A

Free Cash Flow

-$10.98M

+24.6%

Operating Cash Flow

-$10.98M

+23.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ALXOALX Oncology Holdings Inc.

ALXOALX Oncology Holdings Inc.$1.54-1.28%

UNCYUnicycive Therapeutics, Inc.

UNCYUnicycive Therapeutics, Inc.$6.92-6.86%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

HYFTMindWalk Holdings Corp.

HYFTMindWalk Holdings Corp.$1.68-9.19%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.27-7.30%

PMVPPMV Pharmaceuticals, Inc.

PMVPPMV Pharmaceuticals, Inc.$1.12-5.88%

ATYRaTyr Pharma, Inc.

ATYRaTyr Pharma, Inc.$0.47-8.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.38-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

Questions About CAMP

What is the current price of Camp4 Therapeutics?

Camp4 Therapeutics is trading at $4.11 per share.

What is the 52-week range for Camp4 Therapeutics?

Over the past 52 weeks, Camp4 Therapeutics has traded between $1.31 and $7.75.

How much debt does Camp4 Therapeutics have?

As of the most recent reporting period, Camp4 Therapeutics reported total debt of $2.12M.

How much cash does Camp4 Therapeutics have on hand?

Camp4 Therapeutics reported $99.94M in cash and cash equivalents in its most recent financial results.

What is Camp4 Therapeutics’s dividend yield?

Camp4 Therapeutics does not currently have a dividend yield.

Camp4 Therapeutics

Camp4 Therapeutics Financials at a Glance

CAMP News

Camp4 Reports Q2 Revenue Beats Estimates

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Camp4 Therapeutics

CAMP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Camp4 Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CAMP

What is the current price of Camp4 Therapeutics?

What is the 52-week range for Camp4 Therapeutics?

How much debt does Camp4 Therapeutics have?

How much cash does Camp4 Therapeutics have on hand?

What is Camp4 Therapeutics’s dividend yield?

Premium Investing Services